chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Condition aggravated, Neuropathy peripheral
Clinical narrative: G62.9 PERIPHERAL NEUROPATHY 10/11/2022 CHF EXACERBATION, UNSPECIFIED
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 48.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoxia, Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE HYPOXIA
Age: 32.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abnormal uterine bleeding, Coagulopathy, Symptom recurrence
Clinical narrative: ABNL UTERINE BLEEDING DUE TO COAGULOPATHY 3/9/2023  &  3/1/2023  -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Hypersensitivity, Injection site erythema, Injection site infection, Injection site rash
Clinical narrative: Mom called our office today stating that she believes starting yesterday, patient has large red rash on left deltoid area where he received vaccine. I requested that she send photos to our secure triage email and I had Dr. review them. Per Dr., looks more like an allergy type reaction to the vaccine and luckily, we will not have to provide him with another Kinrix in his lifetime. Mom given signs and symptoms to monitor for advancing allergic reaction or injection site infection as well. Zyrtec, Benadryl and Topical Hydrocortisone 1% advised for treatment and to call if anything changes/worsens.
Age: 1.0
Sex: M
Vaccine: HEPA, MMRV, VARCEL
Symptoms: No adverse event
Clinical narrative: NO SYMPTOMS OR ADVERSE REACTIONS NOTED AND NO TREATMENT REQUIRED
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dizziness
Clinical narrative: Patient reports that 3-4 days after receiving the vaccine that he had a few "spells" when he became lightheaded and felt as though he would pass out.  He has seen cardiologist who will be doing some additional tests as it could be related to cardiac issues. He is no longer having this problem.
Age: 11.0
Sex: M
Vaccine: HPV9
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site urticaria
Clinical narrative: Pt was administered HPV9 vaccine in office. Pt noticed he had redness and hives around injection area around 7pm that night. Area was itchy/raised and responded well to Benadryl.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness
Clinical narrative: Complains of "spells" that began 3-4 days after the vaccine of feeling lightheaded and like she was going to pass out.  These "spells" continue on to date. She has seen her PCP who did not detect a cause and stated she did not have any fluid behind her ears that could cause this.  Advised if continue to go back to PCP for further evaluation.
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: severe swelling, redness, warmth and pain entire left upper arm above the elbow
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: PATIENT WAS GIVEN AN EXPIRED VACCINE, VACCINE WAS EXPIRED BY 17 DAYS; PATIENT HAD NO ADVERS REACTION ; NO TREATMENT NECESSARY; PATIENT WAS AND IS DOING FINE ; MODERNA WAS CONTACT AND THEY STATED THAT THE VACCINE WAS STILL GOOD, NO REPEAT NEEDED
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Epilepsy
Clinical narrative: EPILEPSY, UNSPECIFIED
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, MILD
Age: 7.0
Sex: M
Vaccine: DTAP
Symptoms: Expired product administered
Clinical narrative: Vaccine dose given past expire date of 3/1/2023
Age: 84.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Insufficient dose quantity given - 0.3 mls vs. 0.5 mls
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute coronary syndrome, Acute myocardial infarction
Clinical narrative: ACUTE ST ELEVATION MI, INFERIOR WALL ACUTE ST ELEVATION MI, LATERAL WALL ACUTE CORONARY SYNDROME, UNSPECIFIED
Age: 78.0
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: rec'd 3rd dose, pt was asked several times if this was their 2nd dose and he said yes. our record indicated he only had 1.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vaccine expired due to temp
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine expired
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine expired
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ischaemic stroke
Clinical narrative: ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: EXIRED VACCINE
Age: 22.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: vaccine expired
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: vaccine expired
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Guillain-Barre syndrome, Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA GUILLAIN BARRE SYNDROME
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Cholecystitis acute, Hypotension
Clinical narrative: I95.9 HYPOTENSION 4/12/2023 ACUTE CHOLECYSTITIS
Age: 51.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: vaccine expired
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Osteoarthritis
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA 4/3/2023 OSTEOARTHRITIS OF BILAT SHOULDERS
Age: 12.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Crying, Dizziness, Pallor
Clinical narrative: After patient received the above vaccines, pt stated that she felt ok and was ready to go home. At approx 1:17 pm, noticed that the patient was getting pale in color, and asked patient how she felt.  Patient stated that she felt dizzy. This nurse, went to grab the patient and helped lower the patient to the floor. I immediately called for help. At approx 1:18 pm, more nursing staff (help arrived). At approx 1:19 pm, manual blood pressure taken 100/70, HR 90, and 98% SpO2 saturation on RA. Patient was talking and crying. At approx 1:20 pm, gave the patient some apple juice. Patient drank all the juice and remained sitting upright. At approx 1:30 pm, patient wanted to try standing up and was still talking. At approx 1:34 pm, patient c/o lightheadedness again and sat in chair. At approx 1:38 pm, patient wanted to try standing up again. At approx 1:42 pm, patient walked to the lobby and sat back in chair, while mother checked out. This nurse stayed with patient while mother checked out. Patient was able to walk to her car ok.
Age: 51.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE EXPIRED
Age: 22.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/12/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Aortic arteriosclerosis, Hypotension, Neuropathy peripheral
Clinical narrative: G62.9 PERIPHERAL NEUROPATHY 2/15/2023 ATHEROSCLEROSIS OF AORTA I95.9 HYPOTENSION 1/4/2023 ATHEROSCLEROSIS OF AORTA G62.9 PERIPHERAL NEUROPATHY 2/15/2023 ATHEROSCLEROSIS OF AORTA I95.9 HYPOTENSION 1/4/2023 ATHEROSCLEROSIS OF AORTA
Age: 33.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: vaccine expired
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: vaccine expired
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebral artery occlusion, Cerebrovascular accident, Facial paresis
Clinical narrative: I63.512 ACUTE STROKE DUE TO OCCLUSION OF LEFT MIDDLE CEREBRAL ARTERY 4/14/2023 HX OF ISCHEMIC STROKE W UNSPECIFIED RESIDUAL DEFICITS R29.810 LEFT FACIAL MUSCLE WEAKNESS 4/6/2023 HX OF ISCHEMIC STROKE W UNSPECIFIED RESIDUAL DEFICITS
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Aortic arteriosclerosis, Pulmonary embolism
Clinical narrative: I26.99 ACUTE PULMONARY EMBOLISM 3/31/2023 ATHEROSCLEROSIS OF AORTA
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Anxiety, Asthenia, Barium swallow normal
Clinical narrative: Patient is a 64 y.o. female patient with history of small cell lung, CAD status post MI, COPD presented to Medical Center with worsening hypoxic respiratory failure, sepsis, CAP and found to have COVID-19 infection as well.    Acute respiratory failure with hypoxia CAP + COVID treatment as below CT PA study on admission did not show any major PE however concern for mucus plugging/possible aspiration. MBS without aspiration. Required 5L NC initially, later went on HHFNC. CT PA study repeated for increased O2 requirement on 4/24, no PE noted.   Weaned off HHFNC to 4L NC on 4/26. Hypoxic event during her afternoon Radiation Therapy on 4/28, coughing fit lying flat - RT was aborted. O2 requirement increased significantly, back on HHFNC. Continues to require HHFNC, worsening status again on 5/10 AM and placed on BIPAP. CXR repeated on 5/10, with severe emphysema. Back on HHFNC now, 75% and 70L.  BLE venous duplex ordered per Pulm and negative, as discussed with them ordered V/Q scan. Prolonged steroid taper completed, continue diuresis as tolerated.  Discharge to LTAC in progress.    Sepsis, POA- resolved Presumed right-sided community-acquired pneumonia POA CT PA with extensive R side pneumonia, mucous plugging, severe emphysema Blood cx negative to date MRSA, Strep pneumo negative, SCx normal flora after 48 hours Rocephin/azithromycin completed.   COVID-19 Date of onset of symptoms: 4/8 Symptoms present on admission: Cough, dyspnea, weakness Date of covid positive test: 4/11/23 Vaccination status: vaccinated x2 and boosted x1 Imaging: CTPA as above Oxygen requirements on admission: 5L Current oxygen requirements: HHF with bipap, 50%, 60L. Medical therapy: Completed course with remdesivir and steroids Consultants following: Pulm Special isolation end date: 4/22   COPD with acute exacerbation Completed steroid taper on 5/13. Resume home inhalers, nebulization. Small cell lung cancer Currently undergoing radiation treatments Follows with Dr. Rad onc follows and underwent sessions while here, unable to tolerate last session on 4/28. Oncology consulted.    Hyponatremia, resolved Euvolemic, probably SIADH component due to lung disease Na 127 on admission and normalized;  Held free water flushes through PEG tube, diuresis started.  Na improved now.    Esophageal ulceration; suspected candidal infection Dysphagia  Severe malnutrition, POA Due to radiation G tube placed week PTA.  Dietician consulted for TF assistance. S/p completion of Diflucan on 4/20 for suspected candidal esophagitis-no biopsy results in the chart SLP consulted -- initially with ground meats, thin liquids and later advanced. MBS (4/25) without evidence of aspiration.    CAD Denies chest pain. Home ASA, atorvastatin, metoprolol resumed.    Goals of care Changed to DNR-CCA but  OK with intubation on 4/12, later changed to DNI as well.  Wants daughter to be HCPOA Palliative care consulted & follow.    Anxiety Uncontrolled and worsening respiratory status. IV Ativan PRN and Atarax
Sex: F
Vaccine: COVID19-2
Symptoms: Blood culture negative, Blood sodium normal, Bronchial secretion retention, COVID-19, Candida infection
Clinical narrative: Patient is a 64 y.o. female patient with history of small cell lung, CAD status post MI, COPD presented to Medical Center with worsening hypoxic respiratory failure, sepsis, CAP and found to have COVID-19 infection as well.    Acute respiratory failure with hypoxia CAP + COVID treatment as below CT PA study on admission did not show any major PE however concern for mucus plugging/possible aspiration. MBS without aspiration. Required 5L NC initially, later went on HHFNC. CT PA study repeated for increased O2 requirement on 4/24, no PE noted.   Weaned off HHFNC to 4L NC on 4/26. Hypoxic event during her afternoon Radiation Therapy on 4/28, coughing fit lying flat - RT was aborted. O2 requirement increased significantly, back on HHFNC. Continues to require HHFNC, worsening status again on 5/10 AM and placed on BIPAP. CXR repeated on 5/10, with severe emphysema. Back on HHFNC now, 75% and 70L.  BLE venous duplex ordered per Pulm and negative, as discussed with them ordered V/Q scan. Prolonged steroid taper completed, continue diuresis as tolerated.  Discharge to LTAC in progress.    Sepsis, POA- resolved Presumed right-sided community-acquired pneumonia POA CT PA with extensive R side pneumonia, mucous plugging, severe emphysema Blood cx negative to date MRSA, Strep pneumo negative, SCx normal flora after 48 hours Rocephin/azithromycin completed.   COVID-19 Date of onset of symptoms: 4/8 Symptoms present on admission: Cough, dyspnea, weakness Date of covid positive test: 4/11/23 Vaccination status: vaccinated x2 and boosted x1 Imaging: CTPA as above Oxygen requirements on admission: 5L Current oxygen requirements: HHF with bipap, 50%, 60L. Medical therapy: Completed course with remdesivir and steroids Consultants following: Pulm Special isolation end date: 4/22   COPD with acute exacerbation Completed steroid taper on 5/13. Resume home inhalers, nebulization. Small cell lung cancer Currently undergoing radiation treatments Follows with Dr. Rad onc follows and underwent sessions while here, unable to tolerate last session on 4/28. Oncology consulted.    Hyponatremia, resolved Euvolemic, probably SIADH component due to lung disease Na 127 on admission and normalized;  Held free water flushes through PEG tube, diuresis started.  Na improved now.    Esophageal ulceration; suspected candidal infection Dysphagia  Severe malnutrition, POA Due to radiation G tube placed week PTA.  Dietician consulted for TF assistance. S/p completion of Diflucan on 4/20 for suspected candidal esophagitis-no biopsy results in the chart SLP consulted -- initially with ground meats, thin liquids and later advanced. MBS (4/25) without evidence of aspiration.    CAD Denies chest pain. Home ASA, atorvastatin, metoprolol resumed.    Goals of care Changed to DNR-CCA but  OK with intubation on 4/12, later changed to DNI as well.  Wants daughter to be HCPOA Palliative care consulted & follow.    Anxiety Uncontrolled and worsening respiratory status. IV Ativan PRN and Atarax
Sex: F
Vaccine: COVID19-2
Symptoms: Chest X-ray abnormal, Chronic obstructive pulmonary disease, Condition aggravated, Cough, Dysphagia
Clinical narrative: Patient is a 64 y.o. female patient with history of small cell lung, CAD status post MI, COPD presented to Medical Center with worsening hypoxic respiratory failure, sepsis, CAP and found to have COVID-19 infection as well.    Acute respiratory failure with hypoxia CAP + COVID treatment as below CT PA study on admission did not show any major PE however concern for mucus plugging/possible aspiration. MBS without aspiration. Required 5L NC initially, later went on HHFNC. CT PA study repeated for increased O2 requirement on 4/24, no PE noted.   Weaned off HHFNC to 4L NC on 4/26. Hypoxic event during her afternoon Radiation Therapy on 4/28, coughing fit lying flat - RT was aborted. O2 requirement increased significantly, back on HHFNC. Continues to require HHFNC, worsening status again on 5/10 AM and placed on BIPAP. CXR repeated on 5/10, with severe emphysema. Back on HHFNC now, 75% and 70L.  BLE venous duplex ordered per Pulm and negative, as discussed with them ordered V/Q scan. Prolonged steroid taper completed, continue diuresis as tolerated.  Discharge to LTAC in progress.    Sepsis, POA- resolved Presumed right-sided community-acquired pneumonia POA CT PA with extensive R side pneumonia, mucous plugging, severe emphysema Blood cx negative to date MRSA, Strep pneumo negative, SCx normal flora after 48 hours Rocephin/azithromycin completed.   COVID-19 Date of onset of symptoms: 4/8 Symptoms present on admission: Cough, dyspnea, weakness Date of covid positive test: 4/11/23 Vaccination status: vaccinated x2 and boosted x1 Imaging: CTPA as above Oxygen requirements on admission: 5L Current oxygen requirements: HHF with bipap, 50%, 60L. Medical therapy: Completed course with remdesivir and steroids Consultants following: Pulm Special isolation end date: 4/22   COPD with acute exacerbation Completed steroid taper on 5/13. Resume home inhalers, nebulization. Small cell lung cancer Currently undergoing radiation treatments Follows with Dr. Rad onc follows and underwent sessions while here, unable to tolerate last session on 4/28. Oncology consulted.    Hyponatremia, resolved Euvolemic, probably SIADH component due to lung disease Na 127 on admission and normalized;  Held free water flushes through PEG tube, diuresis started.  Na improved now.    Esophageal ulceration; suspected candidal infection Dysphagia  Severe malnutrition, POA Due to radiation G tube placed week PTA.  Dietician consulted for TF assistance. S/p completion of Diflucan on 4/20 for suspected candidal esophagitis-no biopsy results in the chart SLP consulted -- initially with ground meats, thin liquids and later advanced. MBS (4/25) without evidence of aspiration.    CAD Denies chest pain. Home ASA, atorvastatin, metoprolol resumed.    Goals of care Changed to DNR-CCA but  OK with intubation on 4/12, later changed to DNI as well.  Wants daughter to be HCPOA Palliative care consulted & follow.    Anxiety Uncontrolled and worsening respiratory status. IV Ativan PRN and Atarax
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Emphysema, Gastrostomy, Hyponatraemia, Hypoxia
Clinical narrative: Patient is a 64 y.o. female patient with history of small cell lung, CAD status post MI, COPD presented to Medical Center with worsening hypoxic respiratory failure, sepsis, CAP and found to have COVID-19 infection as well.    Acute respiratory failure with hypoxia CAP + COVID treatment as below CT PA study on admission did not show any major PE however concern for mucus plugging/possible aspiration. MBS without aspiration. Required 5L NC initially, later went on HHFNC. CT PA study repeated for increased O2 requirement on 4/24, no PE noted.   Weaned off HHFNC to 4L NC on 4/26. Hypoxic event during her afternoon Radiation Therapy on 4/28, coughing fit lying flat - RT was aborted. O2 requirement increased significantly, back on HHFNC. Continues to require HHFNC, worsening status again on 5/10 AM and placed on BIPAP. CXR repeated on 5/10, with severe emphysema. Back on HHFNC now, 75% and 70L.  BLE venous duplex ordered per Pulm and negative, as discussed with them ordered V/Q scan. Prolonged steroid taper completed, continue diuresis as tolerated.  Discharge to LTAC in progress.    Sepsis, POA- resolved Presumed right-sided community-acquired pneumonia POA CT PA with extensive R side pneumonia, mucous plugging, severe emphysema Blood cx negative to date MRSA, Strep pneumo negative, SCx normal flora after 48 hours Rocephin/azithromycin completed.   COVID-19 Date of onset of symptoms: 4/8 Symptoms present on admission: Cough, dyspnea, weakness Date of covid positive test: 4/11/23 Vaccination status: vaccinated x2 and boosted x1 Imaging: CTPA as above Oxygen requirements on admission: 5L Current oxygen requirements: HHF with bipap, 50%, 60L. Medical therapy: Completed course with remdesivir and steroids Consultants following: Pulm Special isolation end date: 4/22   COPD with acute exacerbation Completed steroid taper on 5/13. Resume home inhalers, nebulization. Small cell lung cancer Currently undergoing radiation treatments Follows with Dr. Rad onc follows and underwent sessions while here, unable to tolerate last session on 4/28. Oncology consulted.    Hyponatremia, resolved Euvolemic, probably SIADH component due to lung disease Na 127 on admission and normalized;  Held free water flushes through PEG tube, diuresis started.  Na improved now.    Esophageal ulceration; suspected candidal infection Dysphagia  Severe malnutrition, POA Due to radiation G tube placed week PTA.  Dietician consulted for TF assistance. S/p completion of Diflucan on 4/20 for suspected candidal esophagitis-no biopsy results in the chart SLP consulted -- initially with ground meats, thin liquids and later advanced. MBS (4/25) without evidence of aspiration.    CAD Denies chest pain. Home ASA, atorvastatin, metoprolol resumed.    Goals of care Changed to DNR-CCA but  OK with intubation on 4/12, later changed to DNI as well.  Wants daughter to be HCPOA Palliative care consulted & follow.    Anxiety Uncontrolled and worsening respiratory status. IV Ativan PRN and Atarax
Sex: F
Vaccine: COVID19-2
Symptoms: Inappropriate antidiuretic hormone secretion, Lung disorder, Malnutrition, Oesophageal candidiasis, Oesophageal ulcer
Clinical narrative: Patient is a 64 y.o. female patient with history of small cell lung, CAD status post MI, COPD presented to Medical Center with worsening hypoxic respiratory failure, sepsis, CAP and found to have COVID-19 infection as well.    Acute respiratory failure with hypoxia CAP + COVID treatment as below CT PA study on admission did not show any major PE however concern for mucus plugging/possible aspiration. MBS without aspiration. Required 5L NC initially, later went on HHFNC. CT PA study repeated for increased O2 requirement on 4/24, no PE noted.   Weaned off HHFNC to 4L NC on 4/26. Hypoxic event during her afternoon Radiation Therapy on 4/28, coughing fit lying flat - RT was aborted. O2 requirement increased significantly, back on HHFNC. Continues to require HHFNC, worsening status again on 5/10 AM and placed on BIPAP. CXR repeated on 5/10, with severe emphysema. Back on HHFNC now, 75% and 70L.  BLE venous duplex ordered per Pulm and negative, as discussed with them ordered V/Q scan. Prolonged steroid taper completed, continue diuresis as tolerated.  Discharge to LTAC in progress.    Sepsis, POA- resolved Presumed right-sided community-acquired pneumonia POA CT PA with extensive R side pneumonia, mucous plugging, severe emphysema Blood cx negative to date MRSA, Strep pneumo negative, SCx normal flora after 48 hours Rocephin/azithromycin completed.   COVID-19 Date of onset of symptoms: 4/8 Symptoms present on admission: Cough, dyspnea, weakness Date of covid positive test: 4/11/23 Vaccination status: vaccinated x2 and boosted x1 Imaging: CTPA as above Oxygen requirements on admission: 5L Current oxygen requirements: HHF with bipap, 50%, 60L. Medical therapy: Completed course with remdesivir and steroids Consultants following: Pulm Special isolation end date: 4/22   COPD with acute exacerbation Completed steroid taper on 5/13. Resume home inhalers, nebulization. Small cell lung cancer Currently undergoing radiation treatments Follows with Dr. Rad onc follows and underwent sessions while here, unable to tolerate last session on 4/28. Oncology consulted.    Hyponatremia, resolved Euvolemic, probably SIADH component due to lung disease Na 127 on admission and normalized;  Held free water flushes through PEG tube, diuresis started.  Na improved now.    Esophageal ulceration; suspected candidal infection Dysphagia  Severe malnutrition, POA Due to radiation G tube placed week PTA.  Dietician consulted for TF assistance. S/p completion of Diflucan on 4/20 for suspected candidal esophagitis-no biopsy results in the chart SLP consulted -- initially with ground meats, thin liquids and later advanced. MBS (4/25) without evidence of aspiration.    CAD Denies chest pain. Home ASA, atorvastatin, metoprolol resumed.    Goals of care Changed to DNR-CCA but  OK with intubation on 4/12, later changed to DNI as well.  Wants daughter to be HCPOA Palliative care consulted & follow.    Anxiety Uncontrolled and worsening respiratory status. IV Ativan PRN and Atarax
Sex: F
Vaccine: COVID19-2
Symptoms: Pneumonia, Positive airway pressure therapy, Radiotherapy, Respiratory disorder, Respiratory failure
Clinical narrative: Patient is a 64 y.o. female patient with history of small cell lung, CAD status post MI, COPD presented to Medical Center with worsening hypoxic respiratory failure, sepsis, CAP and found to have COVID-19 infection as well.    Acute respiratory failure with hypoxia CAP + COVID treatment as below CT PA study on admission did not show any major PE however concern for mucus plugging/possible aspiration. MBS without aspiration. Required 5L NC initially, later went on HHFNC. CT PA study repeated for increased O2 requirement on 4/24, no PE noted.   Weaned off HHFNC to 4L NC on 4/26. Hypoxic event during her afternoon Radiation Therapy on 4/28, coughing fit lying flat - RT was aborted. O2 requirement increased significantly, back on HHFNC. Continues to require HHFNC, worsening status again on 5/10 AM and placed on BIPAP. CXR repeated on 5/10, with severe emphysema. Back on HHFNC now, 75% and 70L.  BLE venous duplex ordered per Pulm and negative, as discussed with them ordered V/Q scan. Prolonged steroid taper completed, continue diuresis as tolerated.  Discharge to LTAC in progress.    Sepsis, POA- resolved Presumed right-sided community-acquired pneumonia POA CT PA with extensive R side pneumonia, mucous plugging, severe emphysema Blood cx negative to date MRSA, Strep pneumo negative, SCx normal flora after 48 hours Rocephin/azithromycin completed.   COVID-19 Date of onset of symptoms: 4/8 Symptoms present on admission: Cough, dyspnea, weakness Date of covid positive test: 4/11/23 Vaccination status: vaccinated x2 and boosted x1 Imaging: CTPA as above Oxygen requirements on admission: 5L Current oxygen requirements: HHF with bipap, 50%, 60L. Medical therapy: Completed course with remdesivir and steroids Consultants following: Pulm Special isolation end date: 4/22   COPD with acute exacerbation Completed steroid taper on 5/13. Resume home inhalers, nebulization. Small cell lung cancer Currently undergoing radiation treatments Follows with Dr. Rad onc follows and underwent sessions while here, unable to tolerate last session on 4/28. Oncology consulted.    Hyponatremia, resolved Euvolemic, probably SIADH component due to lung disease Na 127 on admission and normalized;  Held free water flushes through PEG tube, diuresis started.  Na improved now.    Esophageal ulceration; suspected candidal infection Dysphagia  Severe malnutrition, POA Due to radiation G tube placed week PTA.  Dietician consulted for TF assistance. S/p completion of Diflucan on 4/20 for suspected candidal esophagitis-no biopsy results in the chart SLP consulted -- initially with ground meats, thin liquids and later advanced. MBS (4/25) without evidence of aspiration.    CAD Denies chest pain. Home ASA, atorvastatin, metoprolol resumed.    Goals of care Changed to DNR-CCA but  OK with intubation on 4/12, later changed to DNI as well.  Wants daughter to be HCPOA Palliative care consulted & follow.    Anxiety Uncontrolled and worsening respiratory status. IV Ativan PRN and Atarax
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sepsis, Staphylococcus test negative, Streptococcus test negative, Ultrasound Doppler normal
Clinical narrative: Patient is a 64 y.o. female patient with history of small cell lung, CAD status post MI, COPD presented to Medical Center with worsening hypoxic respiratory failure, sepsis, CAP and found to have COVID-19 infection as well.    Acute respiratory failure with hypoxia CAP + COVID treatment as below CT PA study on admission did not show any major PE however concern for mucus plugging/possible aspiration. MBS without aspiration. Required 5L NC initially, later went on HHFNC. CT PA study repeated for increased O2 requirement on 4/24, no PE noted.   Weaned off HHFNC to 4L NC on 4/26. Hypoxic event during her afternoon Radiation Therapy on 4/28, coughing fit lying flat - RT was aborted. O2 requirement increased significantly, back on HHFNC. Continues to require HHFNC, worsening status again on 5/10 AM and placed on BIPAP. CXR repeated on 5/10, with severe emphysema. Back on HHFNC now, 75% and 70L.  BLE venous duplex ordered per Pulm and negative, as discussed with them ordered V/Q scan. Prolonged steroid taper completed, continue diuresis as tolerated.  Discharge to LTAC in progress.    Sepsis, POA- resolved Presumed right-sided community-acquired pneumonia POA CT PA with extensive R side pneumonia, mucous plugging, severe emphysema Blood cx negative to date MRSA, Strep pneumo negative, SCx normal flora after 48 hours Rocephin/azithromycin completed.   COVID-19 Date of onset of symptoms: 4/8 Symptoms present on admission: Cough, dyspnea, weakness Date of covid positive test: 4/11/23 Vaccination status: vaccinated x2 and boosted x1 Imaging: CTPA as above Oxygen requirements on admission: 5L Current oxygen requirements: HHF with bipap, 50%, 60L. Medical therapy: Completed course with remdesivir and steroids Consultants following: Pulm Special isolation end date: 4/22   COPD with acute exacerbation Completed steroid taper on 5/13. Resume home inhalers, nebulization. Small cell lung cancer Currently undergoing radiation treatments Follows with Dr. Rad onc follows and underwent sessions while here, unable to tolerate last session on 4/28. Oncology consulted.    Hyponatremia, resolved Euvolemic, probably SIADH component due to lung disease Na 127 on admission and normalized;  Held free water flushes through PEG tube, diuresis started.  Na improved now.    Esophageal ulceration; suspected candidal infection Dysphagia  Severe malnutrition, POA Due to radiation G tube placed week PTA.  Dietician consulted for TF assistance. S/p completion of Diflucan on 4/20 for suspected candidal esophagitis-no biopsy results in the chart SLP consulted -- initially with ground meats, thin liquids and later advanced. MBS (4/25) without evidence of aspiration.    CAD Denies chest pain. Home ASA, atorvastatin, metoprolol resumed.    Goals of care Changed to DNR-CCA but  OK with intubation on 4/12, later changed to DNI as well.  Wants daughter to be HCPOA Palliative care consulted & follow.    Anxiety Uncontrolled and worsening respiratory status. IV Ativan PRN and Atarax
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Obstructive sleep apnoea syndrome, Partial seizures, Seizure
Clinical narrative: OBSTRUCTIVE SLEEP APNEA 5/3/2023 LOC-REL IDIO EPI W/SEIZ LOC ONSET INTRCT W/O SE
Age: 52.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthralgia, Joint noise
Clinical narrative: Joints painful and make noise
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Thrombocytopenia
Clinical narrative: OBSTRUCTIVE SLEEP APNEA 12/30/2021 THROMBOCYTOPENIA, UNSPECIFIED (UNKNOWN ETIOLOGY)
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension, Hypoxia
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION HYPOXIA
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Angina pectoris
Clinical narrative: ANGINA, UNSPECIFIED
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Cold sweat, Dizziness, Loss of consciousness, Nausea, Pallor
Clinical narrative: Received vaccines, approximately in an outdoor back to school event, 10 minutes later became dizzy, told mother he was going to faint.  Mom eased client down, minor abrasion, posterior left calf, did not fall.  Other event staff, came and asked to nursing assistance.  This nurse responded.  Client, alert and oriented, clammy, and pale,  Per mom, Client had not gone to bed until 4:30 that morning and had not anything to eat or drink since awakening.  Juice given.  Client then became nauseated and vomited juice given.  Unable to lay person down, outside, asphalt wet from recent rain.  Client accompanied by two nurses inside church lounge.  Client became unconscious, carried into lounge.  Feet elevated, client immediately regained consciousness, alert, answered all questions appropriately.  Additional juice given, color good, skin dry.  After several minutes client feeling better, client sat, stood and walked with standby asst of two.  Client walked to mom's car with standby asst of two.  Mom advised to give client food with protein immediately and push fluids.  Advised to have client rest with feet up for a few hours.
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Skin abrasion, Syncope, Vomiting
Clinical narrative: Received vaccines, approximately in an outdoor back to school event, 10 minutes later became dizzy, told mother he was going to faint.  Mom eased client down, minor abrasion, posterior left calf, did not fall.  Other event staff, came and asked to nursing assistance.  This nurse responded.  Client, alert and oriented, clammy, and pale,  Per mom, Client had not gone to bed until 4:30 that morning and had not anything to eat or drink since awakening.  Juice given.  Client then became nauseated and vomited juice given.  Unable to lay person down, outside, asphalt wet from recent rain.  Client accompanied by two nurses inside church lounge.  Client became unconscious, carried into lounge.  Feet elevated, client immediately regained consciousness, alert, answered all questions appropriately.  Additional juice given, color good, skin dry.  After several minutes client feeling better, client sat, stood and walked with standby asst of two.  Client walked to mom's car with standby asst of two.  Mom advised to give client food with protein immediately and push fluids.  Advised to have client rest with feet up for a few hours.
Age: 49.0
Sex: M
Vaccine: VARZOS
Symptoms: Abnormal dreams, Asthenia, Confusional state, Fatigue, Hyperhidrosis
Clinical narrative: Fever. Had fever dreams that I was gnawing on a severed human head, then walking a pet pig.   Sweating, and the sweat was thick and greazy. My face felt like wax.   Total energy depletion. Malaise. Fatigue.   Loss of sense of time.    Confusion. I thought I was a fly on a head.   Muscle pain all over.   Took aspirin and ibuprofen. Drank pineapple juice. Ate soup.
Age: 49.0
Sex: M
Vaccine: VARZOS
Symptoms: Malaise, Myalgia, Pyrexia, Sensory disturbance, Time perception altered
Clinical narrative: Fever. Had fever dreams that I was gnawing on a severed human head, then walking a pet pig.   Sweating, and the sweat was thick and greazy. My face felt like wax.   Total energy depletion. Malaise. Fatigue.   Loss of sense of time.    Confusion. I thought I was a fly on a head.   Muscle pain all over.   Took aspirin and ibuprofen. Drank pineapple juice. Ate soup.
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypotension, Hypoxia
Clinical narrative: HYPOTENSION HYPOXIA
Age: 67.0
Sex: M
Vaccine: PNC20, VARZOS
Symptoms: Resuscitation, Syncope
Clinical narrative: syncope, had to do a cpr and patient recovered in a few minutes
Age: 89.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 0.5
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: No adverse reaction reported by mother of patient.   Moderna covid 19 age 6 month- 5yr  pink cap 0.2ml was given instead of the Moderna covid 19 age 6 month-5yr blue cap.  At the time of injection we were not aware there were two different presentations for Moderna covid 19 bivalent for ages 6months- 5yrs.  We contacted the manufacturer today and reported the event and received current guidelines to be able to administer this correctly moving forward.
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral, Orthostatic hypotension, Syncope
Clinical narrative: G62.9 NEUROPATHY 4/20/2023 SYNCOPE DUE TO ORTHOSTATIC HYPOTENSION
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Angina pectoris, Symptom recurrence
Clinical narrative: STABLE ANGINA ANGINA, UNSPECIFIED 2/6/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Pyrexia, Urticaria
Clinical narrative: Patient reports developed fever, chills and hives day after vaccination
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Arm sore - expected that, but above elbow red for two weeks, pink one week after that.  Perhaps that means it really took effect?
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Injection site rash, Nausea, Pyrexia
Clinical narrative: 1 day after injection, low grade fever, fatigue and nausea subsiding after 2 day. 5 days after injection severe rash on left arm around injection site.
Age: 65.0
Sex: M
Vaccine: PNC20
Symptoms: Extra dose administered
Clinical narrative: duplicate therapy. system did not list patient got same shot in march 2023
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Cardio-respiratory arrest, Loss of consciousness, Malaise
Clinical narrative: Patient informed medical assistant that she was not feeling well after the administration of the immunization. Patient then passed out. A Code was called and a team was called in to assess the patient to ensure patients safety and wellbeing.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Atypical pneumonia, Bacteraemia, Blood creatinine, COVID-19 pneumonia
Clinical narrative: Patient is a 87 y.o. female patient with history of hypertension, hyperlipidemia, GERD, and Alzheimer's dementia, now presented to Hospital with generalized weakness, near syncopal episode, and pneumonia due to COVID-19.   Generalized weakness  Near syncope Pneumonia due to COVID-19 Patient tested COVID-19 positive, and had chest imaging findings suggestive of an atypical pneumonia. The patient is currently maintaining saturations on room air. Provide gentle fluids just in case presenting symptoms are due to dehydration, although patient's blood pressure, heart rate and creatinine suggest otherwise. Consult PT OT: recommends Home Health with therpay  Plan for discharge home today    Acute cystitis without hematuria Urine culture - Gram Negative Bacilli  Hemodynamically stable, does not appear septic at this time. May potentially be the cause of the patient's generalized weakness. IV Rocephin  Po keflex at discharge    Hypertension Continue home lisinopril  SBP 140s    Hyperlipidemia Continue home pravastatin.   Alzheimer's dementia Continue home donepezil and memantine.   GERD Continue home Pepcid.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Culture urine positive, Cystitis, Presyncope, Pulmonary imaging procedure abnormal, SARS-CoV-2 test positive
Clinical narrative: Patient is a 87 y.o. female patient with history of hypertension, hyperlipidemia, GERD, and Alzheimer's dementia, now presented to Hospital with generalized weakness, near syncopal episode, and pneumonia due to COVID-19.   Generalized weakness  Near syncope Pneumonia due to COVID-19 Patient tested COVID-19 positive, and had chest imaging findings suggestive of an atypical pneumonia. The patient is currently maintaining saturations on room air. Provide gentle fluids just in case presenting symptoms are due to dehydration, although patient's blood pressure, heart rate and creatinine suggest otherwise. Consult PT OT: recommends Home Health with therpay  Plan for discharge home today    Acute cystitis without hematuria Urine culture - Gram Negative Bacilli  Hemodynamically stable, does not appear septic at this time. May potentially be the cause of the patient's generalized weakness. IV Rocephin  Po keflex at discharge    Hypertension Continue home lisinopril  SBP 140s    Hyperlipidemia Continue home pravastatin.   Alzheimer's dementia Continue home donepezil and memantine.   GERD Continue home Pepcid.
Age: 18.0
Sex: F
Vaccine: HPV9
Symptoms: Extra dose administered
Clinical narrative: Pt received 3rd dose of HPV vaccine when not indicated
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Muscular weakness
Clinical narrative: HYPOTENSION 4/4/2023 WEAKNESS OF BILAT LEGS
Age: 18.0
Sex: M
Vaccine: HPV9
Symptoms: Extra dose administered
Clinical narrative: Patient has already received HPV dose 1 and 2 and was inadvertently given a third dose.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Product administration error
Clinical narrative: Pt received HPV vaccine, and mother did not want her to have it.
Age: 6.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abnormal faeces, Anal incontinence, Faeces hard
Clinical narrative: Reports full fecal incontinence 2-3x/day beginning day of vaccination or day after vaccination (GM can't remember) which has been daily and not present prior to vaccination.  She has also had change in stool which is now hard and pebble like.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM 4/12/2023 HTN (HYPERTENSION)
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site vesicles
Clinical narrative: blisters at injection site
Age: 1.25
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: R09.02 HYPOXEMIA 3/10/2023 ACUTE RESPIRATORY FAILURE WITH HYPOXIA
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Delivery, Live birth, Obstructive sleep apnoea syndrome, Twin pregnancy
Clinical narrative: G47.33 OBSTRUCTIVE SLEEP APNEA 4/4/2023 MATERNAL DELIVERY OUTCOME, TWIN BIRTH, BOTH LIVEBORN
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Alcohol use disorder, Alcohol withdrawal syndrome, Illusion, Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA 3/24/2023 SEVERE ALCOHOL USE DISORDER W ALCOHOL WITHDRAWAL, W PERCEPTUAL DISTURBANCE ACUTE NON ST ELEVATION MI 3/24/2023 SEVERE ALCOHOL USE DISORDER W ALCOHOL WITHDRAWAL, W PERCEPTUAL DISTURBANCE
Age: 1.0
Sex: U
Vaccine: MMRV, VARCEL
Symptoms: Accidental overdose, No adverse event
Clinical narrative: No additional AE/PQC.; inadvertently given PROQUAD and VARIVAX concomitantly; This spontaneous report was received from a registered nurse and refers to a 12-month-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported.  On 23-JUN-2023, the patient was inadvertently vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, once, and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, once, concomitantly, (strength, dose#, lot #, expiry date, route and anatomical site of vaccination for both vaccines were not provided) (accidental overdose). No additional adverse event (AE) was provided (no adverse event).
Age: 63.0
Sex: F
Vaccine: PPV
Symptoms: Rash, Rash pruritic
Clinical narrative: itchy rash all over her body starting on 6/19/2023; This spontaneous report was received from patient's daughter and refers to a 63-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions included Sjogren's syndrome. The patient's doctor did bloodwork to check her immune system and the results showed that her immune system was "practically nonexistent ". The patient had none drug reactions/allergies. Concomitant medications included multi vitamin, low dose of prednisone and unspecified thyroid medication.   On 15-JUN-2023, the patient started therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, (dose, anatomical location, lot #, expiry date, and route of administration were not provided) administered for prophylaxis (also reported as "to check for antibodies" and "see if she was able to build antibodies"). The doctor planned to do follow-up bloodwork in a few weeks to test for antibodies. The patient received the vaccine from her primary care doctor, but her immunologist prescribed it.  On 19-JUN-2023 (also reported "a few days after receiving pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23)"), the patient experienced itchy rash all over her body. The patient called her doctor regarding this and the doctor sent her a topical antihistamine cream to use. The patient also reported that when she developed the rash, her doctor was not in so she went to the emergency room (no further details provided by the caller). The patient began using the cream on 22-JUN-2023, but as of 23-JUN-2023 did not felt any relief. The patient's daughter who was the reporter was concerned because she had read that a rash was a serious side effect of the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23). At the time of reporting, the patient had not recovered from the event.  The causal relationship between the event and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.
Age: 15.0
Sex: M
Vaccine: MMRV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: No additional AE; Public Health called and stated that a dose of PROQUAD was inadvertently administered to a 15 year old patient. Caller stated patient did not have any side effects. No additional AE/no PQC.; This spontaneous report was received from a public health educator, referring to a 15-year-old male patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On 22-JUN-2023, the patient was inadvertently vaccinated with 1 dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, vaccination scheme, anatomical site of vaccination, route of administration, lot number and expiration date were not reported) as prophylaxis (product administered to patient of inappropriate age). The patient did not have any side effects.
Age: 0.08
Sex: F
Vaccine: PNC15, RV5
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; temperature excursion; This spontaneous report was received from an medical assistance and refers to an 8-week-old female patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 20-JUN-2023, the patient was vaccinated with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, 0.5 milliliter, lot #W039033, expiration date: 01-OCT-2024, administered for prophylaxis (strength, and route of administration were not provided); and  rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milliliter, lot #1968385, expiration date: 22-MAY-2024, administered orally for prophylaxis (strength was not provided). Pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) underwent temperature excurion three times: in 35.9 Farenheit (F) for 2 minutes, 35.9 Farenheit (F) for 2 minutes and in 49.1 Farenhet (F) for 34 minutes (product storage error). No additional adverse event was reported. ; Sender's Comments:  US-009507513-2307USA004472: